Preoperative inflammatory markers as prognostic predictors after hepatocellular carcinoma resection: data from a western referral center

Table 2 Diagnostic accuracy of the calculated cut-offs for mortality and recurrence

	Cut-off	Sensibility	Specificity	1—Specificity	LR+	LR−
Mortality
NLR	> 1.715	0.639	0.483	0.517	1.236	0.747
PLR	> 115.050	0.375	0.697	0.303	1.236	0.897
MLR	> 1.750	0.917	0.112	0.888	1.033	0.742
Recurrence
NLR	> 2.475	0.307	0.732	0.268	1.146	0.947
PLR	> 100.250	0.520	0.620	0.380	1.367	0.775
MLR	> 2.680	0.747	0.310	0.690	1.082	0.818

The NLR, PLR, and MLR areas under the curve (AUC) for mortality were 0.541 (95%CI 0.451–0.631), 0.479 (95%CI 0.388–0.571), and 0.454 (95%CI 0.365–0.543), respectively. Regarding recurrence, the calculated AUC were 0.479 (95%CI 0.385–0.573), 0.519 (95%CI 0.424–0.614), and 0.469 (95%CI 0.372–0.565), respectively
NLR neutrophil-to-lymphocyte ratio; PLR platelet-to-lymphocyte ratio; MLR monocyte-to-lymphocyte ratio; LR+ positive likelihood ratio; LR− negative likelihood ratio

ISSN: 1471-2482